Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Si Nga, Hong ^a   Medeiros, Pamela ^a   Menezes, Precil ^a   Bridi, Ramaiane ^a   Balbi, André ^a   Ponce, Daniela ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; AGED; ANTIBIOTIC THERAPY; APACHE; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY PATIENT; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; STEROID THERAPY; URINALYSIS; URINE VOLUME; COMPLICATION; DEMOGRAPHY; HOSPITAL EMERGENCY SERVICE; TREATMENT OUTCOME; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; DEMOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; LIPOCALIN-2; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; TREATMENT OUTCOME;

EID: 84938151790     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/413751     Document Type: Article

References (36)

1. V. D. Mayr, M. W. Dünser, V. Greil et al., "Causes of death and determinants of outcome in critically ill patients, " Critical Care, vol. 10, no. 6, article R154, 2006.
2. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, "Epidemiology of severe sepsis in theUnited States: analysis of incidence, outcome, and associated costs of care, " Critical CareMedicine, vol. 29, no. 7, pp. 1303-1310, 2001.
3. E. Silva, M. D. A. Pedro, A. C. B. Sogayar et al., "Brazilian sepsis epidemiological study (BASES study), " Critical Care, vol. 8, no. 4, pp. R251-R260, 2004.
4. P. Lentini, M. de Cal, A. Clementi, A. D'Angelo, and C. Ronco, "Sepsis and AKI in ICUpatients: the role of plasma biomarkers, " Critical Care Research and Practice, vol. 2012, Article ID856401, 5 pages, 2012.
5. A. Zarjou and A. Agarwal, "Sepsis and acute kidney injury, " Journal of theAmerican Society of Nephrology, vol. 22, no. 6, pp. 999-1006, 2011.
6. C. Alberti, C. Brun-Buisson, H. Burchardi et al., "Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study, " Intensive Care Medicine, vol. 28, no. 2, pp. 108-121, 2002.
7. K. Singbartl and J. A. Kellum, "AKI in the ICU: definition, epidemiology, risk stratification, and outcomes, " Kidney International, vol. 81, no. 9, pp. 819-825, 2012.
8. J. Chvojka, R. Sýkora, T. Karvunidis et al., "New developments in septic acute kidney injury, " Physiological Research, vol. 59, no. 6, pp. 859-869, 2010.
9. J. Mishra, C. Dent, R. Tarabishi et al., "Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, " The Lancet, vol. 365, no. 9466, pp. 1231-1238, 2005.
10. G. Wagener, M. Jan, M. Kim et al., "Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery, " Anesthesiology, vol. 105, no. 3, pp. 485-491, 2006.
11. R. Hirsch, C. Dent, H. Pfriem et al., "NGAL is an early predictive biomarker of contrast-induced nephropathy in children, " Pediatric Nephrology, vol. 22, no. 12, pp. 2089-2095, 2007.
12. H. Bachorzewska-Gajewska, J. Malyszko, E. Sitniewska et al., "Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?" Kidney and Blood Pressure Research, vol. 30, no. 6, pp. 408-415, 2007.
13. S. Y. Xu, K. Pauksen, and P. Venge, "Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections, " Scandinavian Journal of Clinical and Laboratory Investigation, vol. 55, no. 2, pp. 125-131, 1995.
14. G. Fjaertoft, T. Foucard, S. Xu, and P. Venge, "Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics, " Acta Paediatrica, vol. 94, no. 6, pp. 661-666, 1992.
15. K. Mori, H. T. Lee, D. Rapoport et al., "Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury, " The Journal of Clinical Investigation, vol. 115, no. 3, pp. 610-621, 2005.
16. P. Devarajan, "NGAL for the detection of acute kidney injury in the emergency room, " Biomarkers in Medicine, vol. 8, no. 2, pp. 217-219, 2014.
17. D. S. Wheeler, P. Devarajan, Q. Ma et al., "Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock, " Critical Care Medicine, vol. 36, no. 4, pp. 1297-1303, 2008.
18. M. Zappitelli, K. K. Washburn, A. A. Arikan et al., "Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study, " Critical Care, vol. 11, no. 4, article R84, 2007.
19. S. M. Bagshaw, M. Bennett, M. Haase et al., "Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus nonseptic acute kidney injury in critical illness, " Intensive Care Medicine, vol. 36, no. 3, pp. 452-461, 2010.
20. J. Mårtensson, M. Bell, A. Oldner, S. Xu, P. Venge, and C.-R. Martling, "Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury, " Intensive Care Medicine, vol. 36, no. 8, pp. 1333-1340, 2010.
21. R. P. Dellinger, M. M. Levy, A. Rhodes et al., "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012, " Intensive Care Medicine, vol. 39, no. 2, pp. 165-228, 2013.
22. A. Earley, D. Miskulin, E. J. Lamb, A. S. Levey, and K. Uhlig, "Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review, " Annals of Internal Medicine, vol. 156, no. 11, pp. 785-795, 2012.
23. S. M. Bagshaw, S. Lapinsky, S. Dial et al., "Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy, " Intensive Care Medicine, vol. 35, no. 5, pp. 871-881, 2009.
24. R. L. Mehta, J. A. Kellum, S. V. Shah et al., "Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury, " Critical Care, vol. 11, no. 2, article R31, 2007.
25. H. Gammelager, C. F. Christiansen, M. B. Johansen, E. Tønnesen, B. Jespersen, and H. T. Sørensen, "Five-year risk of end-stage renal disease among intensive care patients surviving dialysis-requiring acute kidney injury: a nationwide cohort study, " Critical Care, vol. 17, no. 4, article R145, 2013.
26. E.D. Siew, M. E. Matheny, T. A. Ikizler et al., "Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury, " Kidney International, vol. 77, no. 6, pp. 536-542, 2010.
27. M. Plataki, K. Kashani, J. Cabello-Garza et al., "Predictors of Acute kidney injury in septic shock patients: an observational cohort study, " Clinical Journal of the American Society of Nephrology, vol. 6, no. 7, pp. 1744-1751, 2011.
28. R. Challiner, J. P. Ritchie, C. Fullwood, P. Loughnan, and A. J. Hutchison, "Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust, " BMC Nephrology, vol. 15, article 84, 2014.
29. G. R. Stryjewski, E. S. Nylen, M. J. Bell et al., "Interleukin- 6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children, " Pediatric Critical Care Medicine, vol. 6, no. 2, pp. 129-135, 2005.
30. J. Mishra, M. A. Qing, A. Prada et al., "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury, " Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534-2543, 2003.
31. J. Mishra, K. Mori, Q. Ma, C. Kelly, J. Barasch, and P. Devarajan, "Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity, " American Journal of Nephrology, vol. 24, no. 3, pp. 307-315, 2004.
32. H. Trachtman, E. Christen, A. Cnaan et al., "Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury, " Pediatric Nephrology, vol. 21, no. 7, pp. 989-994, 2006.
33. P. Devarajan, "Update onmechanisms of ischemic acute kidney injury, " Journal of theAmericanSociety of Nephrology, vol. 17, no. 6, pp. 1503-1520, 2006.
34. L. Cai, J. Borowiec, S. Xu, W. Han, and P. Venge, "Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances, " Clinica Chimica Acta, vol. 403, no. 1-2, pp. 121-125, 2009.
35. T. L. Nickolas, M. J. O'Rourke, J. Yang et al., "Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury, " Annals of Internal Medicine, vol. 148, no. 11, pp. 810-819, 2008.
36. S. P. Collins, K. W. Hart, C. J. Lindsell et al., "Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events, " European Journal of Heart Failure, vol. 14, no. 9, pp. 1020-1029, 2012.